The September 2022 quarter revenue stood at Rs. 923.78 millions, up 6.99% as compared to Rs. 863.39 millions during the corresponding quarter last year.Profit after tax for the quarter ended September 2022 reported a huge growth of 58.90% to Rs. 201.38  millions from Rs. 126.73 millions.OP of the company witnessed a marginal growth to 277.77 millions from 186.28 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 923.78 863.39 6.99 1855.75 1674.40 10.83 3135.11 2474.50 26.70
Other Income 135.31 54.51 148.23 79.29 104.99 -24.48 158.41 171.80 -7.79
PBIDT 277.77 186.28 49.11 343.94 340.18 1.11 566.35 363.29 55.89
Interest 1.25 1.10 13.64 2.37 2.58 -8.14 5.32 6.53 -18.53
PBDT 276.52 185.18 49.32 341.57 337.60 1.18 561.03 356.76 57.26
Depreciation 20.68 21.08 -1.90 41.91 41.04 2.12 88.06 82.32 6.97
PBT 255.84 164.10 55.90 299.66 296.56 1.05 472.97 274.44 72.34
TAX 54.46 37.37 45.73 80.72 65.40 23.43 120.40 53.00 127.17
Deferred Tax 7.16 -1.66 -531.33 -6.29 -6.44 -2.33 -5.74 9.27 -161.92
PAT 201.38 126.73 58.90 218.94 231.16 -5.29 352.57 221.44 59.22
Equity 57.07 57.07 0.00 57.07 57.07 0.00 57.07 57.07 0.00
PBIDTM(%) 30.07 21.58 39.37 18.53 20.32 -8.78 18.06 14.68 23.05

Albert David Share Price

748.50 0.45 (0.06%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×